idiopathic pulmonary fibrosis

Eli Lilly pushes into pulmonary fibrosis with $99M deal for Mediar's midphase prospect
Fierce Biotech
Fri, 01/10/25 - 11:39 am
Eli Lilly
idiopathic pulmonary fibrosis
IPF
Mediar Therapeutics
Galecto Drops Idiopathic Pulmonary Fibrosis Hopeful After Phase II Flop
BioSpace
Tue, 08/15/23 - 10:10 am
Galecto
clinical trials
GB0139
idiopathic pulmonary fibrosis
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Fierce Biotech
Tue, 05/23/23 - 06:12 pm
Bristol Myers Squibb
clinical trials
BMS-986278
idiopathic pulmonary fibrosis
Aria Pharmaceuticals Secures Six Provisional Patents for Pipeline Candidates
BioSpace
Wed, 08/31/22 - 10:25 am
Aria Pharmaceuticals
patents
lupus
idiopathic pulmonary fibrosis
IPH
chronic kidney disease
With new data, Pliant drug shows promise in tough-to-treat lung disease
BioPharma Dive
Mon, 07/11/22 - 10:28 am
Pliant Therapeutics
idiopathic pulmonary fibrosis
IPF
PLN-74809
clinical trials
BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone
Pharmaforum
Tue, 05/17/22 - 10:23 am
BenevolentAI
idiopathic pulmonary fibrosis
AstraZeneca
artificial intelligence
drug development
Starna Therapeutics emerges with financing for mRNA vaccine and therapies
Endpoints
Mon, 05/16/22 - 10:38 am
Starna Therapeutics
funding
RSV
idiopathic pulmonary fibrosis
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Novartis
Sandoz
generics
Roche
Esbriet
idiopathic pulmonary fibrosis
Boehringer secures FDA’s Breakthrough Therapy Designation for oral therapy
Pharmaceutical Business Review
Fri, 02/25/22 - 09:58 am
Boehringer Ingelheim
idiopathic pulmonary fibrosis
FDA
BI 1015550
breakthrough status
AbbVie ditches fibrosis program it paid Morphic $20M for in 2020
Fierce Biotech
Fri, 02/25/22 - 09:56 am
AbbVie
Morphic Therapeutic
idiopathic pulmonary fibrosis
Endeavor Bio adds $101M to test ex-Eli Lilly, Roche drug in cancer & lung fibrosis
MedCity News
Tue, 02/8/22 - 09:52 am
Endeavor BioMedicines
taladegib
cancer
Eli Lilly
Roche
idiopathic pulmonary fibrosis
The lung fibrosis pipeline thins
EP Vantage
Tue, 09/21/21 - 10:48 am
idiopathic pulmonary fibrosis
IPF
Pliant Therapeutics
PLN-74809
NeRRe nabs £20M to test chronic cough drug in patients with a fatal lung disease
MedCity News
Thu, 07/8/21 - 10:54 am
NeRRe
clinical trial
idiopathic pulmonary fibrosis
clinical trials
Galapagos “win” highlights crowded idiopathic pulmonary fibrosis pipeline
EP Vantage
Fri, 12/4/20 - 10:48 am
Galapagos
GLPG1205
idiopathic pulmonary fibrosis
clinical trials
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward
Xconomy
Sun, 09/27/20 - 11:07 pm
Galecto Biotech
idiopathic pulmonary fibrosis
IPF
GB0139
AbbVie options integrin-based compounds from Morphic, paving way for potential fibrosis treatments
Endpoints
Tue, 08/25/20 - 10:31 am
Morphic Therapeutics
AbbVie
idiopathic pulmonary fibrosis
Roche buys U.S. drugmaker Promedior for up to $1.4 billion to get lung drug
Reuters
Sat, 11/16/19 - 12:01 am
Roche
Promedior
idiopathic pulmonary fibrosis
M&A
Boehringer Ingelheim's Ofev cuts rate of decline by 57% in range of rare lung diseases
Fierce Pharma
Tue, 10/1/19 - 10:59 pm
Boehringer Ingelheim
Ofev
idiopathic pulmonary fibrosis
Biogen stops Phase 2 study in another hit to 'high-risk' pipeline
Biopharma Dive
Tue, 09/17/19 - 03:38 pm
Biogen
clinical trials
IPF
idiopathic pulmonary fibrosis
BG00011
Trevi Therapeutics jumps on the biotech IPO train
Fierce Biotech
Mon, 04/8/19 - 09:47 am
IPOs
Trevi Therapeutics
idiopathic pulmonary fibrosis
levodopa-induced dyskinesia
chronic pruritus

Pages